Overview

A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract

Status:
Recruiting
Trial end date:
2022-10-30
Target enrollment:
0
Participant gender:
All
Summary
To assess the safety of Dextenza compared to an active control, prednisolone acetate suspension, for the treatment of postoperative pain and inflammation following ocular surgery for pediatric cataract.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Ocular Therapeutix, Inc.
Treatments:
Prednisolone
Criteria
Inclusion Criteria:

- Pediatric cataract diagnosis

- Subject is >0 - 3 years of age

Exclusion Criteria:

- Any intraocular inflammation in the study eye

- Ocular hypertension or glaucoma

- Evidence of acute external ocular infections